PortfoliosLab logoPortfoliosLab logo
ASPN vs. TWST
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASPN vs. TWST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aspen Aerogels, Inc. (ASPN) and Twist Bioscience Corporation (TWST). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASPN achieves a 83.04% return, which is significantly lower than TWST's 184.84% return.


ASPN

1D
0.39%
1M
-12.50%
6M
54.17%
YTD
83.04%
1Y
-24.16%
3Y*
-14.58%
5Y*
-31.51%
10Y*
-0.49%

TWST

1D
-0.31%
1M
18.62%
6M
137.51%
YTD
184.84%
1Y
137.58%
3Y*
57.11%
5Y*
-4.20%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASPN vs. TWST - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ASPN
Aspen Aerogels, Inc.
83.04%-76.18%-24.71%33.84%-76.32%198.32%115.08%264.32%-45.52%
TWST
Twist Bioscience Corporation
184.84%-31.74%26.07%54.81%-69.23%-45.23%572.81%-9.05%77.62%

Correlation

The correlation between ASPN and TWST is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.36

Correlation (5Y)
Calculated over the trailing 5-year period

0.41

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2018

0.34

The correlation between ASPN and TWST shifts across timeframes, from 0.29 (1 year) to 0.41 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ASPN:

$429.31M

TWST:

$5.63B

EPS

ASPN:

-$1.36

TWST:

-$1.33

PS Ratio

ASPN:

1.86

TWST:

13.47

PB Ratio

ASPN:

2.01

TWST:

12.25

Total Revenue (TTM)

ASPN:

$230.26M

TWST:

$409.48M

Gross Profit (TTM)

ASPN:

$27.46M

TWST:

$213.23M

EBITDA (TTM)

ASPN:

-$59.70M

TWST:

-$58.23M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASPN vs. TWST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASPN
ASPN Risk / Return Rank: 3737
Overall Rank
ASPN Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
ASPN Sortino Ratio Rank: 4141
Sortino Ratio Rank
ASPN Omega Ratio Rank: 4242
Omega Ratio Rank
ASPN Calmar Ratio Rank: 3333
Calmar Ratio Rank
ASPN Martin Ratio Rank: 3636
Martin Ratio Rank

TWST
TWST Risk / Return Rank: 8989
Overall Rank
TWST Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
TWST Sortino Ratio Rank: 8888
Sortino Ratio Rank
TWST Omega Ratio Rank: 8484
Omega Ratio Rank
TWST Calmar Ratio Rank: 9191
Calmar Ratio Rank
TWST Martin Ratio Rank: 8888
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASPN vs. TWST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aspen Aerogels, Inc. (ASPN) and Twist Bioscience Corporation (TWST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ASPNTWSTDifference
Sharpe ratioReturn per unit of total volatility

-2.31

Sortino ratioReturn per unit of downside risk

-2.35

Omega ratioGain probability vs. loss probability

1.04

1.30

-0.26

Calmar ratioReturn relative to maximum drawdown

-0.34

3.84

-4.18

Martin ratioReturn relative to average drawdown

-0.52

8.37

-8.89

ASPN vs. TWST - Sharpe Ratio Comparison

The current ASPN Sharpe Ratio is -0.26, which is lower than the TWST Sharpe Ratio of 2.04. The chart below compares the historical Sharpe Ratios of ASPN and TWST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ASPN vs. TWST - Drawdown Comparison

The maximum ASPN drawdown since its inception was -95.96%, roughly equal to the maximum TWST drawdown of -94.48%. Use the drawdown chart below to compare losses from any high point for ASPN and TWST.


Loading charts...

Drawdown Indicators


ASPNTWSTDifference

Max Drawdown

Largest peak-to-trough decline

-95.96%

-94.48%

-1.48%

Max Drawdown (1Y)

Largest decline over 1 year

-70.86%

-36.08%

-34.78%

Max Drawdown (3Y)

Largest decline over 3 years

-91.90%

-58.97%

-32.93%

Max Drawdown (5Y)

Largest decline over 5 years

-95.96%

-91.54%

-4.42%

Max Drawdown (10Y)

Largest decline over 10 years

-95.96%

Current Drawdown

Current decline from peak

-91.86%

-56.56%

-35.30%

Average Drawdown

Average peak-to-trough decline

-56.66%

-58.13%

+1.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.47%

16.78%

+29.69%

Volatility

ASPN vs. TWST - Volatility Comparison

The current volatility for Aspen Aerogels, Inc. (ASPN) is 19.35%, while Twist Bioscience Corporation (TWST) has a volatility of 20.52%. This indicates that ASPN experiences smaller price fluctuations and is considered to be less risky than TWST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASPNTWSTDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.35%

20.52%

-1.17%

Volatility (6M)

Calculated over the trailing 6-month period

66.53%

49.16%

+17.37%

Volatility (1Y)

Calculated over the trailing 1-year period

92.63%

67.85%

+24.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

87.27%

76.14%

+11.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.00%

78.32%

-3.32%

Dividends

ASPN vs. TWST - Dividend Comparison

Neither ASPN nor TWST has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ASPN vs. TWST - Financials Comparison

This section allows you to compare key financial metrics between Aspen Aerogels, Inc. and Twist Bioscience Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


40.00M60.00M80.00M100.00M120.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
37.88M
110.72M
(ASPN) Total Revenue
(TWST) Total Revenue
Values in USD except per share items

ASPN vs. TWST - Profitability Comparison

The chart below illustrates the profitability comparison between Aspen Aerogels, Inc. and Twist Bioscience Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-60.0%-40.0%-20.0%0.0%20.0%40.0%60.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
11.3%
51.6%
Portfolio components
ASPN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Aspen Aerogels, Inc. reported a gross profit of 4.28M and revenue of 37.88M. Therefore, the gross margin over that period was 11.3%.

TWST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Twist Bioscience Corporation reported a gross profit of 57.12M and revenue of 110.72M. Therefore, the gross margin over that period was 51.6%.

ASPN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Aspen Aerogels, Inc. reported an operating income of -20.83M and revenue of 37.88M, resulting in an operating margin of -55.0%.

TWST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Twist Bioscience Corporation reported an operating income of -45.86M and revenue of 110.72M, resulting in an operating margin of -41.4%.

ASPN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Aspen Aerogels, Inc. reported a net income of -23.69M and revenue of 37.88M, resulting in a net margin of -62.5%.

TWST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Twist Bioscience Corporation reported a net income of -44.02M and revenue of 110.72M, resulting in a net margin of -39.8%.


Frequently Asked Questions


ASPN and TWST have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TWST has higher volatility (20.52%) compared to ASPN (19.35%). In terms of maximum drawdown, ASPN dropped -95.96% vs TWST's -94.48%.

TWST currently has the higher Sharpe Ratio (2.04 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASPN and TWST

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer